Tao Jiaying, Shi Zhixian, Li Mulan, Li Tingting
Department of Obstetrics and Gynecology, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
West China Second University Hospital, Sichuan University, Chengdu, China.
Front Oncol. 2024 Jul 15;14:1412206. doi: 10.3389/fonc.2024.1412206. eCollection 2024.
Growing teratoma syndrome (GTS) is a rare condition that arises secondary to malignant germ cell tumors. It is characterized by an enlarging abdominal mass during or after chemotherapy, normal tumor markers, and histopathological indications of mature teratoma components. Awareness of GTS is limited, and it is often mistaken for disease progression or recurrence. This misdiagnosis can lead to delayed treatment and increased risk of complications. Therefore, early identification of GTS is crucial to avoid unnecessary systemic treatments and reduce financial burden. GTS is unresponsive to chemotherapy or radiotherapy and complete surgical resection is the sole therapeutic strategy. In this report, we present a case of GTS in a 20-year-old female following treatment for immature teratoma, alongside a review of the relevant literature aimed at enriching our insight into the clinical manifestations of GTS.
成熟性畸胎瘤综合征(GTS)是一种继发于恶性生殖细胞肿瘤的罕见病症。其特征为化疗期间或化疗后腹部肿块增大、肿瘤标志物正常,以及组织病理学显示有成熟畸胎瘤成分。对GTS的认识有限,它常被误诊为疾病进展或复发。这种误诊会导致治疗延迟并增加并发症风险。因此,早期识别GTS对于避免不必要的全身治疗和减轻经济负担至关重要。GTS对化疗或放疗无反应,完整手术切除是唯一的治疗策略。在本报告中,我们呈现了一例20岁女性在接受未成熟畸胎瘤治疗后发生GTS的病例,并对相关文献进行综述,旨在加深我们对GTS临床表现的认识。